What is NDC 71335-2327?

71335-2327 is the product NDC for Meloxicam, Meloxicam 15 mg/1 tablet, listed with the FDA by Bryant Ranch Prepack. It has 10 package NDCs, shown above in 10- and 11-digit form.

Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Meloxicam?

147 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Meloxicam NDC 71335-2327 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-2327Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-2327Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71335-2327-0	71335232700	20 TABLET in 1 BOTTLE (71335-2327-0)Marketed from Jan 8, 2024
71335-2327-1	71335232701	30 TABLET in 1 BOTTLE (71335-2327-1)Marketed from Jan 8, 2024
71335-2327-2	71335232702	60 TABLET in 1 BOTTLE (71335-2327-2)Marketed from Jan 8, 2024
71335-2327-3	71335232703	90 TABLET in 1 BOTTLE (71335-2327-3)Marketed from Jan 8, 2024
71335-2327-4	71335232704	14 TABLET in 1 BOTTLE (71335-2327-4)Marketed from Jan 8, 2024
71335-2327-5	71335232705	100 TABLET in 1 BOTTLE (71335-2327-5)Marketed from Jan 8, 2024
71335-2327-6	71335232706	7 TABLET in 1 BOTTLE (71335-2327-6)Marketed from Jan 8, 2024
71335-2327-7	71335232707	10 TABLET in 1 BOTTLE (71335-2327-7)Marketed from Jan 8, 2024
71335-2327-8	71335232708	15 TABLET in 1 BOTTLE (71335-2327-8)Marketed from Jan 8, 2024
71335-2327-9	71335232709	28 TABLET in 1 BOTTLE (71335-2327-9)Marketed from Jan 8, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Meloxicam
Generic name (nonproprietary): meloxicam
Active ingredients: Meloxicam — 15 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Bryant Ranch PrepackNDC labeler code 71335
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077929
Marketing start: Jul 19, 2006
Listing expires: Dec 31, 2026
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 71335-2327_9e73d381-68bd-4c4a-926d-78ce6b4a5ee0SPL ID 9e73d381-68bd-4c4a-926d-78ce6b4a5ee0SPL set ID e5860527-f338-4073-9bb4-9f5f079469e7RxCUI 152695UNII VG2QF83CGL
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335232700 followed by a unit qualifier and the quantity

Package 71335-2327-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 8, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

Meloxicam is a non-steroidal anti-inflammatory drug indicated for: Osteoarthritis (OA) (1.1) Rheumatoid Arthritis (RA) (1.2) Juvenile Rheumatoid Arthritis (JRA) in patients who weigh ≥60 kg (1.3) 1.1 Osteoarthritis (OA) Meloxicam is indicated for relief of the signs and symptoms of osteoarthritis [ see Clinical Studies (14.1)]. 1.2 Rheumatoid Arthritis (RA) Meloxicam is indicated for relief of the signs and symptoms of rheumatoid arthritis [ see Clinical Studies (14.1) ]. 1.3 Juvenile Rheumatoid Arthritis (JRA) Pauciarticular and Polyarticular Course Meloxicam is indicated for relief of the signs and symptoms of pauciarticular or polyarticular course Juvenile Rheumatoid Arthritis in patients…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71335-2327

What is NDC 71335-2327?: 71335-2327 is the product NDC for Meloxicam, Meloxicam 15 mg/1 tablet, listed with the FDA by Bryant Ranch Prepack. It has 10 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Meloxicam.
What is the active ingredient?: Meloxicam.
Who is the labeler?: Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Meloxicam?: 147 other product NDCs are listed under this name. See all Meloxicam NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Meloxicam NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Meloxicam	Meloxicam 7.5 mg/1	TabletOral	Direct_Rx	72189-683	72189-0683-3072189-0683-6072189-0683-72+1 more
Meloxicam	Meloxicam 15 mg/1	TabletOral	Direct_Rx	72189-684	72189-0684-30
meloxicam	Meloxicam 7.5 mg/1	TabletOral	Coupler LLC	67046-1342	67046-1342-03
Meloxicam	Meloxicam 15 mg/1	TabletOral	Advanced Rx of Tennessee, LLC	80425-0584	80425-0584-0180425-0584-0280425-0584-03
Meloxicam	Meloxicam 15 mg/1	TabletOral	Advanced Rx of Tennessee, LLC	80425-0585	80425-0585-0180425-0585-0280425-0585-03
Meloxicam	Meloxicam 15 mg/1	TabletOral	Advanced Rx of Tennessee, LLC	80425-0586	80425-0586-0180425-0586-0280425-0586-03
meloxicam	Meloxicam 15 mg/1	TabletOral	Coupler LLC	67046-0891	67046-0891-03
meloxicam	Meloxicam 7.5 mg/1	TabletOral	Coupler LLC	67046-0057	67046-0057-03
Meloxicam	Meloxicam 7.5 mg/1	TabletOral	Medcore LLC	82461-719	82461-0719-30
Meloxicam	Meloxicam 7.5 mg/1	TabletOral	AiPing Pharmaceutical, Inc	11788-046	11788-0046-0111788-0046-0511788-0046-10

All 148 Meloxicam NDCs

Other NDCs under ANDA 077929

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077929
Product	Strength	Form · route	Labeler	Product NDC
Meloxicam	Meloxicam 7.5 mg/1	TabletOral	NCS HealthCare of KY, LLC dba Vangard Labs	0615-8040
Meloxicam	Meloxicam 15 mg/1	TabletOral	NCS HealthCare of KY, LLC dba Vangard Labs	0615-8124
Meloxicam	Meloxicam 15 mg/1	TabletOral	A-S Medication Solutions	50090-6671
Meloxicam	Meloxicam 15 mg/1	TabletOral	A-S Medication Solutions	50090-6672
Meloxicam	Meloxicam 7.5 mg/1	TabletOral	A-S Medication Solutions	50090-6803
Meloxicam	Meloxicam 7.5 mg/1	TabletOral	A-S Medication Solutions	50090-7875
Meloxicam	Meloxicam 7.5 mg/1	TabletOral	Northwind Health Company, LLC	51655-177
Meloxicam	Meloxicam 15 mg/1	TabletOral	Northwind Health Company, LLC	51655-571
Meloxicam	Meloxicam 15 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-653
Meloxicam	Meloxicam 15 mg/1	TabletOral	Redpharm Drug	67296-1317
Meloxicam	Meloxicam 15 mg/1	TabletOral	NuCare Pharmaceuticals, Inc.	68071-2184
Meloxicam	Meloxicam 7.5 mg/1	TabletOral	Cipla USA Inc.	69097-158
Meloxicam	Meloxicam 15 mg/1	TabletOral	Cipla USA Inc.	69097-159
Meloxicam	Meloxicam 15 mg/1	TabletOral	REMEDYREPACK INC.	70518-0200
Meloxicam	Meloxicam 15 mg/1	TabletOral	REMEDYREPACK INC.	70518-1630
Meloxicam	Meloxicam 7.5 mg/1	TabletOral	REMEDYREPACK INC.	70518-2631
Meloxicam	Meloxicam 7.5 mg/1	TabletOral	Asclemed USA, Inc.	76420-325
Meloxicam	Meloxicam 15 mg/1	TabletOral	Asclemed USA, Inc.	76420-326
Meloxicam	Meloxicam 7.5 mg/1	TabletOral	Advanced Rx of Tennessee, LLC	80425-0043
Meloxicam	Meloxicam 15 mg/1	TabletOral	Advanced Rx of Tennessee, LLC	80425-0083

Showing 20 of 22.